Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Curious about which cash back credit cards don't charge an annual fee? Discover options that allow you to earn rewards without extra costs.
26,317 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Lockheed Martin has surged in 2026, led by a robust backlog and growing cash flow that underpin a genuine stock 2026 ...
Jim Cramer signals a clear pecking order in payments, naming Klarna as the one to avoid while highlighting Affirm and...
In a market eager for AI breakthroughs, one tech stock with eyes stands out as a long-term buy. This article breaks d...
Tesla posts stronger AI-driven software and cash flow, while Rivian reports revenue with mounting automotive losses. ...
A surprisingly strong first quarter has some investors asking if Stellantis can shake off years of underperformance. ...
Amazon plans an unprecedented AI data-center buildout, with a $200 billion capex target for 2026. This article unpack...
Spotify is showing improving cash flow and user growth, but the stock faces FX headwinds and a lingering legal disput...
AutoZone faced a sharp May drop after mixed results and rising costs. This guide breaks down the drivers, what they m...
Cathie Wood is known for bold bets, but recently her moves hint at bargain-hunting in big-name tech. This article bre...
Cathie Wood and Ark Invest pulled cash from several holdings in a single session, sparking questions about risk, liqu...
Two retail giants, two very different paths to trillion-dollar status. This guide breaks down the case for Walmart an...